David H. Margolin

David H. Margolin has extensive work experience in the pharmaceutical and medical fields. David H. currently holds the position of VP, Clinical Development at uniQure, Inc. and previously served as the Vice President of Clinical Development at Alkermes. Prior to these roles, they were the Senior VP of Clinical and Translational Medicine at Cerevance Inc. and the Head of Development for Multiple Sclerosis at Sanofi Genzyme. David H. also held the position of Senior Medical Director at Sanofi Genzyme, where they were responsible for overseeing the development program for the Lemtrada® (alemtuzumab) and leading clinical studies across various neurologic and rare disease indications. Additionally, they have earlier experience as an Associate Neurologist at Brigham and Women's Hospital, an Instructor in Neurology at Harvard Medical School, and an Assistant in Neurology at Massachusetts General Hospital.

David H. Margolin earned an MD, PhD degree from the University of Pennsylvania School of Medicine between 1982 and 1990, majoring in Medicine, Immunology, Anatomy, and Structural Biology. David H. also obtained certification as a Board Certified Adult Neurologist from the American Board of Psychiatry and Neurology in June 1995.